H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Census population 249,422. Virginia Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chesapeake clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chesapeake storefront.
Chronic Wound Treatment That Works in Chesapeake, VA for clinics & physicians. Effective chronic wound tre… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Chesapeake is 40.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Virginia includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for chronic wound treatment, not a walk-in clinic.
National Chronic Wound Treatment That Works notes (how the product actually works)JM reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Chesapeake is 12.9% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Chesapeake warehouse or a five-star local review. What you get is chronic wound treatment from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JM, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 12.9% of adults — 0.9 points above the U.S. 12% figure. Obesity is 40.1%; arthritis is 26.5%. That is place-level BRFSS modeling, not a clinic census and not a Chesapeake trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Virginia compliance risk.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Palmetto GBA LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Virginia is in CMS MAC JM, administered by Palmetto GBA. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Ask for the IFU, the lot-traceability packet, and the Palmetto GBA article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Chesapeake fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Chesapeake, VA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chesapeake is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chesapeake — 0.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Virginia Part B wound biologics follow this contractor (siblings: NC, SC, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chesapeake. Useful for joint-program math; still needs a diagnosis and privileging.
No Chesapeake storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.